Oruka Therapeutics (ORKA) Assets (2010 - 2026)
Oruka Therapeutics' Assets came in at $1.14 billion for Q2 2026, up 218.8% from $357.42 million a year earlier and up 125.9% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Oruka Therapeutics' Assets was $488.62 million, up 23.4% from FY2024.
- Assets carries a five-year compound annual growth rate of 57.5% (FY2020 to FY2025).
- Going back by year, Assets was $396.02 million in FY2024 (+946.0%), $37.86 million in FY2023 (-12.1%), $43.09 million in FY2022 (-21.6%) and $54.92 million in FY2021 (+8.9%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2010.
- Year-over-year, Assets has increased for eight consecutive quarters, with growth averaging 510.6% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2024 (growth of 956.8%), and the weakest in Q2 2022 (a decline of 26.4%).
- Business Quant data shows ORKA's Assets at $504.48 million (Q1 2026), $488.62 million (Q4 2025) and $509.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Oruka Therapeutics | 5.29 Bn | 3.34 Bn | - | 1.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Bn |
| Mar 31, 2026 | 504.48 Mn |
| Dec 31, 2025 | 488.62 Mn |
| Sep 30, 2025 | 509.25 Mn |
| Jun 30, 2025 | 357.42 Mn |
| Mar 31, 2025 | 377.11 Mn |
| Dec 31, 2024 | 396.02 Mn |
| Sep 30, 2024 | 414.09 Mn |
| Jun 30, 2024 | 33.84 Mn |
| Mar 31, 2024 | 36.71 Mn |
| Dec 31, 2023 | 37.86 Mn |
| Sep 30, 2023 | 39.18 Mn |
| Jun 30, 2023 | 41.08 Mn |
| Mar 31, 2023 | 42.06 Mn |
| Dec 31, 2022 | 43.09 Mn |
| Sep 30, 2022 | 44.97 Mn |
| Jun 30, 2022 | 48.10 Mn |
| Mar 31, 2022 | 51.01 Mn |
| Dec 31, 2021 | 54.92 Mn |
| Sep 30, 2021 | 60.19 Mn |
API Access
Oruka Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();